David Dworaczyk PhD

Dr. Dworaczyk has done extensive work with numerous Healthcare, Pharma, Biotech, Healthcare Informatics, Diagnostic and CRO focused Venture and Private Equity investment groups assessing and evaluating investment opportunities from an operational, strategic and business potential perspective. Most recently, he directed Life and Health Sciences Strategic Development at Oracle and has also served as COO for Comprehensive Clinical Development, Sr. Vice President, General Manager & COO at Generation Health/MetaDiagnostic, a start-up focused on molecular diagnostics, genomics and personalized medicine, and was COO for M2Gen, a for-profit subsidiary of the Moffitt Cancer Center. His responsibilities included leading all operational functions across multiple business units with extensive experience in genomics/biomarkers, translational research, patient targeted drug development, gene based trial matching, precision/personalized medicine, healthcare analytics, population health as well as the integration and effective use of “Big/Complex” data and healthcare analytics.